Cart
sales@molnova.com
Home -
Products -
Others -
Other Targets -
Cyanidin3-(6-(2-(p)-coumarate-β-D-glucopyranosyl)-β-D-glucopyranosyl)-5-glucopyranoside
Cyanidin3-(6-(2-(p)-coumarate-β-D-glucopyranosyl)-β-D-glucopyranosyl)-5-glucopyranoside
CAS No. 771448-35-2
Cyanidin3-(6-(2-(p)-coumarate-β-D-glucopyranosyl)-β-D-glucopyranosyl)-5-glucopyranoside( ——— )
Catalog No. M39732 CAS No. 771448-35-2
Cyanidin3-(6-(2-(p)-coumarate-β-D-glucopyranosyl)-β-D-glucopyranosyl)-5-glucopyranoside
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameCyanidin3-(6-(2-(p)-coumarate-β-D-glucopyranosyl)-β-D-glucopyranosyl)-5-glucopyranoside
-
NoteResearch use only, not for human use.
-
Brief DescriptionCyanidin3-(6-(2-(p)-coumarate-β-D-glucopyranosyl)-β-D-glucopyranosyl)-5-glucopyranoside
-
DescriptionCyanidin3-(6-(2-(p)-coumarate-β-D-glucopyranosyl)-β-D-glucopyranosyl)-5-glucopyranoside
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number771448-35-2
-
Formula Weight———
-
Molecular Formula———
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Peroxydehydrotumulos...
5alpha,8alpha-Peroxydehydrotumulosic acid exhibits inhibitory effects against the Epstein-Barr virus early antigen (EBV-EA) activation induced by 12-O-tetradecanoylphorbol-13-acetate (TPA) in Raji cells.
-
Luciferase-IN-1
Luciferase-IN-1, a luciferase inhibitor, is utilized in the study of bacterial and fungal infections.
-
Kazinol B
Kazinol B, a prenylated flavan with a dimethyl pyrane ring, is an inhibitor of nitric oxide (NO) production. Kazinol B improves insulin sensitivity by enhancing glucose uptake via the insulin-Akt signaling pathway and AMPK activation. Kazinol B has the potential for diabetes mellitus research.
